Edward Morrow Atkinson III's Net Worth
$18.2 Million
Who is Edward Morrow Atkinson III?
Edward Morrow Atkinson III has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include 89bio, Inc., and VERTEX PHARMACEUTICALS INC / MA.
SEC CIK
Edward Morrow Atkinson III's CIK is 0001914164
Past Insider Trading and Trends
2024 was Edward Morrow Atkinson III's most active year for acquiring shares with 5 total transactions. Edward Morrow Atkinson III's most active month to acquire stocks was the month of January. 2024 was Edward Morrow Atkinson III's most active year for disposing of shares, totalling 10 transactions. Edward Morrow Atkinson III's most active month to dispose stocks was the month of January. 2023 saw Edward Morrow Atkinson III paying a total of $60,712.50 for 43,650 shares, this is the most they've acquired in one year. In 2024 Edward Morrow Atkinson III cashed out on 23,022 shares for a total of $10,551,221.67, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
89bio, Inc. (ETNB) Snapshot price: $8.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
$10.26 | -$95,625.00 |
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
$9.02 | -$91,600.00 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
EVP, Chief Technical Ops. Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -46.91% | -14.11K |
$479.91 | -$6,772,559.04 | 15.97K |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
| +88.35% | 14.11K |
—
|
—
| 30.08K |
May 14
| |||
Form 4
| -13.71% | -2.54K |
$429.67 | -$1,090,073.76 | 15.97K |
Scheduled
|
Feb 23 - Feb 26
| ||
Form 4
| -6.09% | -1.20K |
$421.77 | -$506,545.77 | 18.51K |
Scheduled
|
Feb 21
| ||
Form 4
| -14.81% | -3.43K |
$422.13 | -$1,446,644.30 | 19.71K |
Scheduled
|
Feb 16 - Feb 20
| ||
Form 4
| -7.01% | -1.75K |
$421.43 | -$735,398.80 | 23.14K |
Scheduled
|
Feb 9 - Feb 12
| ||
Form 4
| +79.28% | 11K |
—
|
—
| 24.88K |
Feb 6 - Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||